Analysis Of Outcome According To Risk Factors In The Randomized Phase Iii Turandot Trial Evaluating First-Line Bevacizumab-Containing Therapy For Her2-Negative Locally Recurrent/Metastatic Breast Cancer (Lr/Mbc)
CANCER RESEARCH（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined